Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (5)

« Back to Publications

Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans.

Srnic N. et al, (2025), Dis Model Mech, 18

Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans.

Westcott FA. et al, (2024), Eur J Endocrinol, 191, 463 - 472

Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk.

Westcott F. et al, (2024), Atherosclerosis, 394

Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.

Green CJ. et al, (2022), Eur J Endocrinol, 186, 367 - 377

Risk factors associated with post-operative uveitis after cataract surgery: a retrospective case-control study.

Halim J. et al, (2022), Eye (Lond), 36, 198 - 205